Peptides TIL

Peptide News

Trump’s FDA Nominee Faces Peptide Regulation Battle Ahead of Senate Confirmation

President Donald Trump’s nominee to lead the Food and Drug Administration, Dr. Heidi Overton, is stepping into one of the most contentious health policy fights of the year: whether unapproved peptides should be more widely available through compounding pharmacies. The Pro‑Peptide Push In July, Health and ...

Pain Drug Targets Peptide Receptors: What Cebranopadol Means for the Peptide Trend

Adneuris Therapeutics has announced new data on its investigational pain therapy cebranopadol at PAINWeek 2026. While cebranopadol itself is not a peptide, its mechanism of action directly involves nociceptin/orphanin FQ peptide (NOP) and µ‑opioid peptide (MOP) receptors — highlighting how peptides remain central to modern medicine ...

As Cardi B, Jennifer Aniston, & Celebs Normalize Peptides, Regulators Advance

As 2026 comes to a close, the global wellness and beauty landscape has been utterly transformed by a single, powerful buzzword: peptides. From the meticulously curated skincare routines of Grammy-winning artists to the elite recovery protocols of legendary athletes, these microscopic chains of amino acids have ...

Zealand Pharma Capitalizes on Market Dip: Aggressively Snapping Up Shares Ahead of Crucial Peptide Milestones

Zealand Pharma (Nasdaq: ZEAL; CPH: ZEAL) is pressing ahead with its DKK 1.3 billion (~USD 190 million) share buyback program, acquiring another 136,000 shares in late August. The move lifts total repurchases to 2.86 million shares worth DKK 868.6 million, or 5.22% of the company’s share capital — a rare show of financial ...